Three-dimensional holograph vector of atomic interaction field (3D-HoVAIF): A novel rotation-translation invariant 3D structure descriptor and its applications to peptides

Journal of Peptide Science

Volumn 13, Issue 8, 2007, Pages 549-566

  Tian, Feifei ^a,b   Zhou, Peng ^a   Lv , Fenglin ^b   Song, Rong ^b   Li, Zhiliang ^a  

^a CHONGQING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin converting enzyme (ACE) inhibitor; Bitter tasting dipeptide; Functional food; Quantitative structure activity relationship (QSAR); Three dimensional holograph vector of atomic interaction field (3D HoVAIF)

Indexed keywords

CAPTOPRIL; DIPEPTIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANALYTIC METHOD; ARTICLE; BITTER TASTE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME INHIBITOR COMPLEX; FUNCTIONAL FOOD; GENETIC ALGORITHM; INTERMETHOD COMPARISON; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PARTIAL LEAST SQUARES REGRESSION; PEPTIDE ANALYSIS; PHARMACODYNAMICS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STATISTICAL MODEL; STRUCTURE ANALYSIS; THREE DIMENSIONAL HOLOGRAPH VECTOR OF ATOMIC INTERACTION FIELD;

CAPTOPRIL; HUMANS; IMAGING, THREE-DIMENSIONAL; MODELS, MOLECULAR; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY;

EID: 34548271443     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.892     Document Type: Article

References (88)

1. Tdeschini R, Consonni V. Handbook of Molecular Descriptors. Wiley-VCH: Weinheim, 2000.
2. Wiener H. Correlation of heats of isomerization and differences in heats of vaporiza-tion of isomers, among the paraffin hydrocarbons. J. Phys. Chem. 1948; 52: 2636-2638.
3. Hosoya H. Topological index. A new proposed quantity characterizing the topological nature of structural isomers of saturated hydrocarbons. Bull. Chem. Soc. 1971; 44: 2332-2339.
4. Randic M. On characterization of molecular branching. J. Am. Chem. Soc. 1975; 97: 6609-6615.
5. Balaban AT. High discrimmation distance-based topological index. Chem. Phys. Lett. 1982; 89: 399-404.
6. Katritzky AR, Lobanov VS, Karelson M. QSPR: the correlation and quantitative prediction of chemical and physical properties from structure. Chem. Soc. Rev. 1995; 24: 279-287.
7. Katritzky AR, Maran U, Lobanov VS, Karelson M. Structurally diverse quantitative structure-property relationship correlations of technologically relevant physical properties. J. Chem. Inf. Comput. Sci. 2000; 40: 1-18.
8. Kier LB, Hall LH. An electrotopological state index for atoms in molecules. Pharm. Res. 1990; 7: 801-807.
9. Hall LH, Kier LB. The electrotopological state: structure information at the atomic level for molecular graph. J. Chem. Inf. Comput. Sci. 1991; 31: 76-83.
10. Wild DJ, Blankley CJ. Comparison of 2D fingerprint types and hierarchy level selection methods for structural grouping using Ward's clustering. J. Chem. Inf. Comput. Sci. 2000: 40: 155-162.
11. Flower DR. On the properties of bit string-based measures of chemical similarity. J. Chem. Inf. Comput. Sci. 1998; 38: 379-386.
12. Xue L, Godden JW, Bajorath J. Database searching for compounds with similar biological activities using short binary bit string representations of molecules. J. Chem. Inf. Comput. Sci. 1999; 39: 881-886.
13. González MP, Terán C. A TOPS-MODE approach to predict adenosine kinase inhibition. Bioorg. Med. Chem. Lett. 2004; 14: 3077-3079.
14. González MP, Terán C. A TOPS-MODE approach to predict affinity for A1 adenosine receptors. 2-(Arylamino) adenosine analogues. Bioorg. Med. Chem. 2004; 12: 2985-2993.
15. Cramer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988; 110: 5959-5967.
16. Klebe G, Abraham U, Mietzner T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994; 37: 4130-4146.
17. Doweyko AM. The hypothetical active site lattice. An approach to Modeling active sites from data on inhibitor molecules. J. Med. Chem. 1988; 31: 1396-1406.
18. Goodford PJ. A computational procedure for determining energetically favorable binding sites on biologically important molecules. J. Med. Chem. 1985; 28: 849-857.
19. Jain AN, Dietterich TG, Lathrop RH, Chapman D, Critchlow RE, Webster TA, Lozaoperez T. COMPASS-a shape-based machine learning tool for drug design. J. Comput. Aided Mol. Des. 1994; 8: 635-652.
20. Todeschini R, Lasagni M, Marengo E. New molecular descriptors for 2D and 3D structures. Theory. J. Chemom. 1994; 8: 263-272.
21. Todeschini R, Gramatice P, Provenzani R. Weighted holistic invariant molecular descriptors. Part 2. Theory development and applications on modeling physicochemical properties of polycyclic aromatic hydrocarbons. Chemom. Intell. Lab. Syst. 1995; 27: 221-229.
22. Bravi G, Gancia E, Mascagni P, Pegna M, Todeschini R, Zaliani A. MS-WHIM, new 3D theoretical descriptors derived from molecular surface properties: a comparative 3D-QSAR study in a series of steroids. J. Comput. Aided Mol. Des. 1997; 11: 79-92.
23. Silverman BD, Platt DE. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition. J. Med. Chem. 1996; 39: 2129-2140.
24. Ferguson AM, Heritage T, Jonathon P, Pack SE, Phillips L, Rogan J, Snaith PJ. EVA: a new theoretically based molecular descriptor for use in QSAR/QSPR analysis. J. Cornput. Aided Mol. Des. 1997; 11: 143-147.
25. Baumann K. Distance profiles (DiP): a translationally and rotationally invariant 3D structure descriptor capturing steric properties of molecules. Quant. Struct.-Act. Relat. 2002; 21: 507-519.
26. Liu S, Cao C, Li Z. Approach to estimation and prediction for normal boiling point (NBP) of alkanes based on a novel molecular distance edge (MDE) vector λ. J. Chem. Inf. Comput. Sci. 1998; 38: 387-394.
27. Liu S, Cai S, Cao C, Li Z. Molecular electronegative distance vector (MEDV) relating to 15 properties of alkanes. J. Chem. Inf. Comput. Sci. 2000; 40: 1337-1348.
28. Liu S, Liu H, Yu B, Cao C, Li Z. Investigation on quantitative relationship between chemical shift of carbon-13 nuclear magnetic resonance spectra and molecular topological structure based on a novel atomic distance-edge vector (ADEV). J. Chemom. 2001; 15: 427-438.
29. Liao C, Chen Z, Yin Z, Li Z. Preliminary approach to estimation and prediction of infrared spectroscopy for Mannich bases by atomic electronegativity distance vector (VAED). Comput. Biol. Chem. 2003; 27: 229-239.
30. Levitt M. Protein folding by restrained energy minimization and molecular dynamics. J. Mol. Biol. 1983; 170: 723-764.
31. Hahn M. Receptor surface models. 1. Definition and construction. J. Med. Chem. 1995; 38: 2080-2090.
32. Kellogg GE, Serous SF, Abraham DJ. HINT-a new method of empirical hydrophobic field calculation for CoMFA. J. Comput. Aided Mol. Des. 1991; 5: 545-552.
33. Hasel W, Hendrikson TF, Still WC. A rapid approximation to the solvent accessible surface areas of atoms. Tetrahed. Comp. Method. 1988; 1: 103-116.
34. Pei J, Wang Q, Zhou J, Lai L. Estimating protein-ligand binding free energy: atomic solvation parameters for partition coefficient and solvation free energy calculation. Proteins 2004: 57: 651-664.
35. Wold S, Rube A, Wold H, Dunn WJ. The collinearity problem in linear regression-the partial least squares (PLS) approach to generalized inverses. Siam J. Sci. Stat. Comput. 1984; 5: 735-743.
36. Hoskuldsson P. PLS regression methods. J. Chemom. 1988; 2: 211-228.
37. Wold S, Sjöström M, Eriksson L. PLS regression: a basic tool of chemometrics. Chemom. Intell. Lab. Syst. 2001; 58: 109-130.
38. Leonard JT, Roy K. On selection of training and test sets for the development of predictive QSAR models. QSAR Comb. Sci. 2006; 25: 235-251.
39. SYantai-Kis C, Kövesdi I, Kéri G, Orfi L. Validation subset selections for extrapolation oriented QSPAR models. Mol. Divers. 2003; 7: 37-43.
40. Gramatica P, Pilutti P, Papa E. Validated QSAR prediction of OH tropospheric degradation of VOCs: splitting into training-test sets and consensus Modeling. J. Chem. Inf. Comput. Sci. 2004; 44: 1794-1802.
41. Golbraikh A, Tropsha A. Beware of q21. J. Mol. Graphics Modell. 2002; 20: 269-276.
42. Tropsha A, Gramatica P, Gombar VK. The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb. Sci. 2003: 22: 69-77.
43. Vincent M, Marchand B, Remond G, Jaguelin-Guinamant S, Damien G, Portevin B, Baumal JY, Volland J, Bouchet J, Lambert P, Serldz B, Luitjen W, Lauibie M, Schiavi P. Synthesis and ACE inhibitory activity of the stereoisomers of perindopril (S9490) and perindoprilate (S9780). Drug Des. Discov. 1992; 9: 11-28.
44. Cushman DW, Cheung HS, Sabo EF, Ondetti MA. Angiotensin-converting enzyme inhibitors: evolution of a new class of antihypertensive drugs. In Angiotensin-Converting Enzyme Inhibitors: Mechanisms of Action and Clinical Implications, Horovitz ZP (ed.). Urban and Schwarzenberg: Baltimore, 1981; 3-25.
45. Hellberg S, Eriksson L, Jonsson J, Lindgren F, Sjöström M, Skagerberg B, Wold S, Andrews P. Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. Int. J. Pept. Protein Res. 1991: 37: 414-424.
46. Cocchi M, Johansson E. Amino acids characterization by GRID and multivariate data analysis. Quant. Struct.-Act. Relat. 1993; 12: 1-8.
47. Collantes ER, Dunn WJ. Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues. J. Med. Chem. 1995; 38: 2705-2713.
48. Zaliani A, Gancia E. MS-WHIM scores for amino acids: a new 313-description for peptide QSAR and QSPR studies. J. Chem. Inf. Comput. Sci. 1999; 39: 525-533.
49. Li Z, Fu B, Wang Y, Liu S. On structural parameterization and molecular modeling of peptide analogues by molecular electronegativity edge vector (VMEE): estimation and prediction for biological activity of pentapeptides. J Chin. Chem. Soc. 2001; 48: 937-944.
50. Liu S, Yin C, Wang L. Combined MEDV-GA-MLR method for QSAR of three panels of steroids, dipeptides, and COX-2 inhibitors. J. Chem. Inf. Comput. Sci. 2002; 42: 749-756.
51. Liu S, Yin C, Cal S, Li Z. A novel MHDV descriptor for dipeptide QSAR studies. J. Chin. Chem. Soc. 2001; 48: 253-260.
52. Liu S, Yin C, Cai S, Li Z. QSAR study of steroid benchmark and dipeptides based on MEDV-13. J. Chem. Inf. Comput. Sci. 2001; 41: 321-329.
53. Mei H, Liao Z, Zhou Y, Li Z. A new set of amino acid descriptors and its application in peptide QSARs. Biopolym. Pept. Sci. 2005; 80: 775-786.
54. Zhou P, Zhou Y, Wu S, Li B. Tian F, Li Z. A new descriptor of amino acids based on the atomic interaction field. Chin. Sci. Bull. 2006; 51: 524-529.
55. Tian F, Zhou P, Li Z. T-scale as a novel vector of topological descriptors for amino acids and its application in QSARs of peptides. J. Mol. Struct. 2007; 830: 106-115.
56. Zhou P, Tian F, Li B, Wu S, Li Z. Genetic algorithm-based virtual screening of combinative mode for peptide/protein. Acta Chim. Sinica 2006; 64: 691-697.
57. Adler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJP, Zuker CS. A novel family of mammalian taste receptors. Cell 2000; 100: 693-702.
58. Matsunami H, Montmayeur J, Buck LB. A family of candidate taste receptors in human and mouse. Nature 2000; 404: 601-604.
59. Asao M, Iwamara H, Akamatsu M, Fujita T. Quantitative structure-activity relationships of bitter thresholds of amino acids, peptides and their derivatives. J. Med. Chem. 1987; 30: 1873-1879.
60. Jonsson J, Eriksson L, Hellberg S, Sjostroem M, Wold S, Multivariate parametrization of 55 coded and non-coded amino acids. Quant. Struct.-Act. Relat. 1989; 8: 203-209.
61. de Armas RR, Diaz HG, Molin R, González MP, Uriarte E. Stochastic-based descriptors studying peptides biological properties: modeling the bitter tasting threshold of dipeptides. Bioorg. Med. Chem. 2004; 12: 4815-4822.
62. Cushman DW, Ondetti MA. Design of potent competitive inhibition of angiotensin-converting enzyme. Biochemistry 1977; 16: 5484-5488.
63. Natesh R, Schwager SL, Evans HR, Sturrock ED, Acharya KR. Structural details on the binding of antihypertensive drugs captopril andenalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 2004; 43: 8718-8724.
64. Hypercube Inc., HyperChem 7.5, 2004; www.hyper.com.
65. Fujitsu Inc., BioMedCAChe 6.1, 2004; http:///www.cachesoftware.com.
66. Stewart JJP. MOPAC: A semiepirical molecular orbital program. J. Comput.-Aided Mol. Des. 1990; 4: 1-105.
67. Umetrics Inc., SIMCA-P 10.0, 2002; http://www.umetrics.com.
68. Leardi R, González AL. Genetic algorithms applied to feature selection in PLS regression: how and when to use them. Chemom. Intell. Lab. Syst. 1998; 41: 195-207.
69. Houck CR, Joines J, Kay M. A genetic algorithm for function optimization: a matlab implementation. ACM Trans. Math. Softw. 1996; 22: 1-14.
70. Eigenvector Research Inc., PLS Toolbox 3.0, 2003; http://www.eigenvector.com.
71. Math Works Inc., Matlab 6.1, 2001; http://www.mathworks.com.
72. Wold S, Eriksson L. Statistical validation of QSAR results. In Chemometrics Methods in Molecular Design. van de Waterbeemd H (ed.). Wiley-VCH: Weinheim, 1995; 309-318.
73. Hellberg S, Sjostrom M, Skagerberg B, Wold S. Peptide quantitative structure-activity relationships, a multivariate approach. J. Med. Chem. 1987; 30: 1126-1135.
74. Andersson PM, Sjöström M, Lundstedt T. Preprocessing peptide sequences for multivariate sequence-property analysis. Chemom. Intell. Lab. Syst. 1998; 42: 41-50.
75. Lejon T, Strøm MB, Svendsen JS. Antibiotic activity of pentadecapeptides modelled from amino acid descriptors. J. Pept. Sci. 2001; 7: 74-81.
76. Jenssen H, Gutteberg TJ, Lejon T. Modeling of anti-HSV activity of lactoferricin analogues using amino acid descriptors. J. Pept. Sci. 2005; 11: 97-103.
77. Wu J, Aluko RE, Nakai S. Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure-activity relationship modeling of peptides containing 4-10 amino acid residues. QSAR Comb. Sci. 2006; 25: 873-880.
78. Genst ED, Areskoug D, Decanniere K, Muyldermans S, Andersson K. Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design. J. Biol. Chem. 2002; 277: 29897-29907.
79. Guan P, Doytchinova IA, Walshe VA, Borrow P, Flower DR. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A*0201. J. Med. Chem. 2005; 48: 7418-7425.
80. Ponce YM, Marrero RM, Castro EA, de Armas RR, Díaz HG, Zaldivar VR, Torrens F. Protein quadratic indices of the "macromolecular pseudograph's α-carbon atom adjacency matrix". 1. Prediction of are repressor alanine-mutant's stability. Molecules 2004; 9: 1124-1147.
81. Cho SJ, Zheng W, Tropsha A. Rational combinatorial library design. 2. rational design of targeted combinatortal peptide libraries using chemical similarity probe and the inverse QSAR approaches. J. Chem. Inf. Comput. Sci. 1998; 33: 259-268.
82. Lin Z, Wu Y, Zhu B, Ni B, Wang L. Toward the quantitative prediction of T-Cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A*0201. J. Comput. Biol. 2004; 11: 683-694.
83. de Armas RR, Díaz HG, Molina R, Uriarte E. Stochastic-based descriptors studying biopolymers biological properties: extended MARCH-INSIDE methodology describing antibacterial activity of lactoferricin derivatives. Biopolymers 2005; 77: 247-256.
84. Baroni M, Clement S, Cruciani G, Kettaneh-Wold S, Wold S. D-optimal designs in QSAR. Quant. Struct.-Act. Relat. 1993; 12: 225-231.
85. de Aguiar PF, Bourguignon B, Khots MS, Massart DL, Phan-Than-Luu R. D-optimal designs. Chemom. Intell. Lab. Syst. 1995; 30: 199-210.
86. Silva SS, Malcata FX. Caseins as source of bioactive peptides. Int. Dairy J. 2005; 15: 1-15.
87. Pripp AH, Ardõ Y. Modeling relationship between angiotensin-(I)-converting enzyme inhibition and the bitter taste of peptides. Food Chemistry 2007; 102: 880-888.
88. Cheung HS, Wang FL, Ondetti MA, Sabo EF, Cushman DW. Binding of peptide substrates and inhibitors of angiotensin-coverting enzyme. J. Biol. Chem. 1980; 255: 401-407.